Global Point-of-Care Testing Market (POC): Global Industry Analysis and Forecast 2018-2026 by Product type, By End-User and By Region

Publish Date: Oct 2021

Category: Healthcare, Pharmaceuticals & Medical Devices

Publisher: Maximize Market Research

Status: Publish

Market Scenario

Global Point-of-Care Testing Market (POC) was valued US$ 14Bn in 2017 and is anticipated to reach US$ 30Bn by 2026 at a CAGR of about 10.0% during a forecast.Global Point-of-Care Testing Market Global Point-of-Care (POC) Testing Market by product type, By Product Type, By End User and by region. Based on product type point of care market is segmented into Glucose Monitoring, Cardiac Markers, Infectious Diseases Testing, Cholesterol Testing, Coagulation Monitoring, Pregnancy And Fertility Testing, Haematology Testing, Blood Gas Testing & Others. By End-User are segmented in Clinics, Home, Laboratories, Assisted living healthcare facilities, Hospitals. Geographically into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.

The driving factor for the point of care market is due to Rising in usage of home-based glucose monitoring systems, Coagulation Monitoring, Infectious Diseases Testing, in trending Pregnancy And Fertility Testing, developing technology and innovative launching scheme and best offers to eventually reduce public and national spending on health, These devices are being highly used for the rapid diagnosis of disease conditions for the early detection and management of the disease are the factor of growth in point of care market. High logistics costs and huge investment will be the restrains for point of care market.

Global Point-of-Care (POC) Testing Market is segmented into by product, by Product Type, by End-user Type, and by geography. In terms Product Type, Infectious Diseases Testing will be in higher demand due to rising Point-of-care diagnostic are offering various schemes such as ease of use in remote areas, technological advancements, and lowered price points, tests are used in finger stick or capillary samples will be the key factor to boost the point of care market. In End, User segment Home Care will be fastest growing department due to Growing concern for early-stage disease detection and to avoid the occurrence of any chronic condition is expected to drive the remote monitoring and raise demand for rapid tests are a growth opportunity in the point-of-care testing market.

Among region, Asia Pacific is expected to grow at the highest CAGR during the forecast period. The market growth in the region can be attributed to the emerging economies, increasing in disposal income, Large-scale rising population, changing lifestyle and early safety and precaution will lead the step in these regions to boost the point-of-care testing market in the Asia Pacific.

Abbott Laboratories, Akers Biosciences, Inc., Alfa Scientific Designs, Inc, Amnisure International, Arlington Scientific, Inc, Becton Dickinson (BD), Biotron Diagnostics, Inc, Boson Biotech Co. Ltd, Chembio Diagnostic Systems, Inc, DRG International, Inc, Daktari Diagnostics, Diasys Diagnostic Systems Gmbh, Diazyme Laboratories, Inc., EKF Diagnostics Holdings plc, Eurolyser Diagnostica Gmbh, Getein Biomedical, Inc,. Hema Diagnostic Systems, LLC, Jant Pharmacal Corporation, Nova Biomedical, Corp., Princeton Biomeditech Corporation, Teco Diagnostics, Wama Diagnostica.

Scope of Global Point-of-Care (POC) Testing Market

Global Point-of-Care (POC) Testing Market by Product Type:

• Glucose Monitoring
• Cardiac Markers
• Infectious Diseases Testing
• Cholesterol Testing
• Coagulation Monitoring
• Pregnancy and Fertility Testing
• Hematology Testing
• Blood Gas Testing
• Others
Global Point-of-Care (POC) Testing Market by End-User Type

• Clinics
• Home Care
• Laboratories
• Assisted living healthcare facilities
• Hospitals
Global Point-of-Care (POC) Testing Market by Region

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America
Key Player analyzed in the Report:

• Abbott
• Beckman Coulter Inc.
• Instrumentation Laboratory
• Johnson & Johnson
• Nova Biomedical
• Qiagen
• Roche Diagnostics Limited
• Siemens AG
• Abaxis, Inc.
• Abbott Laboratories
• Alfa Scientific Designs, Inc.
• ARKRAY, Inc.
• Ascencia Diabetes Care Holdings AG
• Becton Dickinson and Company
• bioMerieux SA
• F. Hoffmann-La Roche AG
• LamdaGen Corporation
• Medtronic Public Limited Company
• Nova Biomedical

Table of Contents
Ask For Analyst

Choose License Type